孫宇琦??張洋??任春娜??劉嬋娟
[摘要] 目的 探討血清PCT聯(lián)合CRP對(duì)重癥感染患者的檢測(cè)價(jià)值。 方法 選取2012年1月~2016年12月于我院ICU入住的感染患者68例,按感染嚴(yán)重程度分為重癥感染組37例,局部感染組31例。選取同期入住ICU未合并感染的患者60例為對(duì)照組。入住ICU時(shí),抽取外周靜脈血20mL,采用雙抗夾心免疫化學(xué)發(fā)光法檢測(cè)降鈣素原(PCT),免疫散射速率比濁法檢測(cè)C反應(yīng)(CRP)。PCT≥0.5ng/L定義為陽性,CRP≥10mg/L定義為陽性。 結(jié)果 重癥感染組和局部感染組血清PCT和CRP水平均顯著高于對(duì)照組(P<0.05);且重癥感染組血清PCT和CRP水平均顯著高于局部感染組(P<0.05)。重癥感染組和局部感染組PCT和CRP陽性率均顯著高于對(duì)照組(P<0.05);重癥感染組PCT陽性率顯著高于局部感染組(P<0.05);重癥感染組和局部感染組CRP陽性率均為100.00%,差異無統(tǒng)計(jì)學(xué)意義(P>0.05)。PCT敏感性為81.96%,特異性75.16%;CRP敏感性為60.54%,特異性49.25%;聯(lián)合應(yīng)用PCT和CRP檢測(cè),敏感性為87.25%,特異性81.56%。 結(jié)論 血清PCT聯(lián)合CRP檢測(cè),有助于重癥感染的早期診斷和鑒別,效果優(yōu)于單一PCT或CRP檢測(cè),值得臨床推廣應(yīng)用。
[關(guān)鍵詞] 重癥感染;降鈣素原;C反應(yīng)蛋白;檢測(cè)
[中圖分類號(hào)] R459.7 [文獻(xiàn)標(biāo)識(shí)碼] A [文章編號(hào)] 2095-0616(2017)11-152-03
Diagnostic value of serum PCT combined with CRP in patients with severe infection
SUN Yuqi ZHANG Yang REN Chunna LIU Chanjuan
Clinical Laboratory,Second Affiliated Hospital of Mudanjiang Medical College,Mudanjiang 157000,China
[Abstract] Objective To investigate the diagnostic value of serum PCT combined with CRP in severe infection. Methods 68 cases of infected patients admitted in ICU from January 2012 to December 2016 were selected and divided into severe infection group (37 cases) and local infection group(31 cases),according to the severity of infection.At the Same period,60 patients admitted in ICU without infection were selected as the control group.On the day of admission,20mL of peripheral venous blood was collected.The anti-calcitonin(PCT) was detected by double-antibody sandwich immuno-chemiluminescence method,and the C reaction protein(CRP) was detected by turbidimetric method.PCT≥0.5ng/L was defined as positive,and CRP≥10mg/L was defined as positive. Results The serum levels of PCT and CRP in severe infection group and local infection group were significantly higher than those in control group(P<0.05),and the levels of PCT and CRP in severe infection group were significantly higher than those in local infection group(P<0.05).The positive rates of PCT and CRP in severe infection group and local infection group were significantly higher than those in control group(P<0.05).PCT positive rate in severe infection group was significantly higher than that in local infection group(P<0.05).CRP positive rate was 100.00% for both severe infection group and local infection group,the difference was not statistically significant (P>0.05).PCT sensitivity was 81.96%,specificity was 75.16%.CRP sensitivity was 60.54%,and specificity was 49.25%.The sensitivity and specificity were 87.25% and 81.56%,respectively. Conclusion Serum PCT combined with CRP detection is helpful to the early diagnosis and differential diagnosis of severe infection.And the effect is better than single PCT or CRP detection,which is worthy of popularization and application.
[Key words] Severe infection;Procalcitonin;C-reactive protein;Inspection
重癥監(jiān)護(hù)病房(ICU)收治的患者多數(shù)是危重患者,很容易發(fā)生感染。尤其是重癥感染患者,死亡率高達(dá)35%~70%,一直是導(dǎo)致患者死亡的主要原因[1]。重癥感染嚴(yán)重影響患者的生活質(zhì)量和生命安全,是醫(yī)患關(guān)系緊張的原因之一。目前,臨床上
尚無統(tǒng)一的重癥感染診斷標(biāo)準(zhǔn)。C反應(yīng)蛋白(C reaction protein,CRP)和降鈣素原(procalcitonin,PCT)對(duì)于全身炎癥反應(yīng)和感染具有重要的評(píng)估價(jià)值,在機(jī)體受到感染時(shí)其水平可明顯升高[2-3]。本文通過聯(lián)合檢測(cè)血清PCT和CRP,分析其對(duì)重癥感染的診斷和預(yù)后判斷價(jià)值。現(xiàn)報(bào)道如下。
1 資料與方法
1.1 一般資料
選取2012年1月~2016年12月于我院ICU入住的感染患者68例,按感染嚴(yán)重程度分為重癥感染組37例,局部感染組(無全身癥狀的局部感染)31例。重癥感染組符合重癥感染診斷標(biāo)準(zhǔn)[4]。排除合并急性心肌梗死、惡性腫瘤等能引起CRP升高疾病者。選取同期入住ICU未合并感染的患者60例為對(duì)照組。重癥感染組男19例,女18例;年齡45~78歲,平均(65.6±16.5)歲;其中菌血癥12例,消化系統(tǒng)感染20例,呼吸道感染25例,泌尿系統(tǒng)感染11例。局部感染組男16例,女15例;年齡45~80歲,平均(64.7±15.6)歲;呼吸道感染13例、泌尿道感染8例,傷口感染10例。對(duì)照組男35例,女25例;年齡46~80歲,平均(65.2±17.2)歲。三組患者在性別組成和年齡方面比較差異無統(tǒng)計(jì)學(xué)意義(P>0.05),具有可比性。
1.2 PCT和CRP檢測(cè)
所有患者入住ICU時(shí),抽取外周靜脈血20mL,EDTA抗凝,于羅氏cobas e 411電化學(xué)發(fā)光全自動(dòng)免疫分析儀采用雙抗夾心免疫化學(xué)發(fā)光法檢測(cè)降鈣素原(PCT),免疫散射速率比濁法檢測(cè)C反應(yīng)(CRP)。PCT≥0.5ng/L定義為陽性,CRP≥10mg/L定義為陽性。
1.3 統(tǒng)計(jì)學(xué)處理
統(tǒng)計(jì)分析所有資料采用SPSS20.0進(jìn)行分析處理,計(jì)量資料以()表示,采用t檢驗(yàn),計(jì)數(shù)資料以百分比表示,采用χ2檢驗(yàn),P<0.05為差異有統(tǒng)計(jì)學(xué)意義。
2 結(jié)果
2.1 PCT和CRP水平比較
重癥感染組和局部感染組血清PCT和CRP水平均顯著高于對(duì)照組(P<0.05);且重癥感染組血清PCT和CRP水平均顯著高于局部感染組(P<0.05)。
2.2 PCT和CRP陽性率比較
重癥感染組和局部感染組PCT和CRP陽性率均顯著高于對(duì)照組(P<0.05);重癥感染組PCT陽性率顯著高于局部感染組(P<0.05);重癥感染組和局部感染組CRP陽性率均為100.00%,差異無統(tǒng)計(jì)學(xué)意義(P>0.05)。
2.3 診斷價(jià)值
PCT敏感性為81.96%,特異性75.16%;CRP敏感性為60.54%,特異性49.25%;聯(lián)合應(yīng)用PCT和CRP檢測(cè),敏感性為87.25%,特異性81.56%。見表3。
3 討論
CRP是一種非特異性的炎性因子,在機(jī)體受到外來刺激,如細(xì)菌感染,組織損傷等,由肝臟分泌的一種炎癥急性時(shí)相蛋白,其在惡性腫瘤、感染和組織損傷患者中表達(dá)水平明顯高于健康人群,可作為臨床診斷感染的檢測(cè)指標(biāo)[5-7]。研究顯示,CRP可用于不同病原菌感染的診斷中,如>100mg/L預(yù)示細(xì)菌感染,<50mg/L預(yù)示病毒感染,而革蘭氏陰性菌感染時(shí)CRP水平可達(dá)500mg/L以上[8-10]。但是由于CRP是一種非特異性的炎性指標(biāo),缺乏特異性,且容易受到多種因素的影響,在患者機(jī)體存在其他炎癥反應(yīng)時(shí),亦可引起CRP水平升高。PCT是一個(gè)由116個(gè)氨基酸組成的降鈣素前肽物質(zhì),常作為診斷感染的指標(biāo)。正常情況下,PCT主要由甲狀腺C細(xì)胞分泌,病理狀態(tài)下肝臟、腎臟和肌肉等均可在內(nèi)毒素細(xì)胞因子的刺激下分泌[11-13]。健康人血清中,PCT維持較低的水平,病態(tài)下機(jī)體可在短時(shí)間內(nèi)大量釋放PCT。
三組血清PCT和CRP水平變化比較見表1。本組數(shù)據(jù)顯示,重癥感染組和局部感染組血清PCT和CRP水平均顯著高于對(duì)照組(P<0.05);且重癥感染組血清PCT和CRP水平均顯著高于局部感染組(P<0.05),表明血清PCT和CRP與感染的嚴(yán)重程度相關(guān),是重癥感染性疾病診斷的有效指標(biāo)。三組PCT和CRP陽性率比較見表2。但是重癥感染組和局部感染組CRP陽性率均為100.00%,差異無統(tǒng)計(jì)學(xué)意義(P>0.05),表明CRP在判斷感染嚴(yán)重程度方面不如PCT。王艷等[14]報(bào)道稱,在有全身表現(xiàn)的重癥感染時(shí),在判斷感染的嚴(yán)重程度方面,PCT優(yōu)于CRP,與本文結(jié)果一致。皮白雉等[1]對(duì)重癥細(xì)菌感染患者血清降鈣素原和C-反應(yīng)蛋白水平檢測(cè)發(fā)現(xiàn),重癥細(xì)菌感染患者PCT和CRP陽性率分別為93.3%和76.6%,健康人群為5.0%和18.3%,有助于重癥細(xì)菌感染患者。研究表明,在嚴(yán)重細(xì)菌感染患者中,與CRP相比,PCT升高的早、恢復(fù)正常也更快,與感染病情嚴(yán)重程度相關(guān)性更高[15],這與本文發(fā)現(xiàn)PCT對(duì)于重癥感染的診斷敏感性和特異性均高于CRP結(jié)果一致。當(dāng)聯(lián)合應(yīng)用PCT和CRP檢測(cè),對(duì)于重癥感染的診斷敏感性和特異性均提高(見表3),表明PCT聯(lián)合CRP檢測(cè)有助于提高重癥感染的診斷和鑒別。
綜上所述,血清PCT聯(lián)合CRP檢測(cè),有助于重癥感染的早期診斷和鑒別,效果優(yōu)于單一PCT或CRP檢測(cè),值得臨床推廣應(yīng)用。
[參考文獻(xiàn)]
[1] 皮白雉,方強(qiáng),姚小英,等.重癥細(xì)菌感染患者血清降鈣素原聯(lián)合C-反應(yīng)蛋白水平檢測(cè)的應(yīng)用研究[J].中華醫(yī)院感染學(xué)雜志,2016,26(8):1718-1720.
[2] Dong Z,Jianxin Z,Haraguchi G,et al.[Procalcitonin for the differential diagnosis of infectious and non-infectious systemic inflammatory response syndrome after cardiac operation][J].Zhonghua wei zhong bing ji jiu yi xue,2014,26(7):478-479.
[3] Nijman RG,Moll HA, Smit FJ,et al.C-reactive protein,procalcitonin and the lab-score for detecting serious bacterial infections in febrile children at the emergency department:a prospective observational study[J].The Pediatric infectious disease journal,2014,33(11):e273-e279.
[4] 李志.重癥感染ICU患者血清降鈣素原和C-反應(yīng)蛋白變化及診斷價(jià)值[J].實(shí)用臨床醫(yī)藥雜志,2016,20(5):70-72.
[5] 張柘,沈穎,鄭勇,等.血清CRP與PCT和紅細(xì)胞沉降率對(duì)骨科腫瘤患者術(shù)后感染的診斷意義[J].中華醫(yī)院感染學(xué)雜志,2016,26(9):2024-2026.
[6] 楊興易.重癥感染的幾個(gè)基本問題[J].中華急診醫(yī)學(xué)雜志,2004,13(2):142~143.
[7] 李國(guó)智. 重癥感染患者降鈣素原與C反應(yīng)蛋白、血小板計(jì)數(shù)的監(jiān)測(cè)與病情危重程度相關(guān)性分析[J].中國(guó)傷殘醫(yī)學(xué),2014,22(19):112-113.
[8] Wu CW,Wu JY,Chen CK,et al.Does procalcitonin,C-reactive protein,or interleukin-6 test have a role in the diagnosis of severe infection in patients with febrile neutropenia?A systematic review and meta-analysis[J].Supportive Care in Cancer,2015,23(10):2863-2872.
[9] Zunder SM,Vollaard AM,van Nieuwkoop C,et al. Prognostic value of pro-adrenomedullin,procalcitonin and C-reactive protein in predicting outcome of febrile urinary tract infection[J].Clinical Microbiology and Infection,2014,20(10):1048-1054.
[10] 賈麗娜.重癥監(jiān)護(hù)室感染病原菌的分布及其耐藥性與臨床相關(guān)因素分析[J].南寧:廣西中醫(yī)藥大學(xué),2014,6.
[11] 李詩陽,王日興,呂有凱,等.老年重癥感染患者血清降鈣素原與C-反應(yīng)蛋白聯(lián)合檢測(cè)的臨床價(jià)值[J].中國(guó)老年學(xué)雜志,2016,36(8):1960-1961.
[12] Helfritz FA,Lehner F,Manns MP,et al.Perioperative White Blood Cell Count as a Marker for Patient and Graft Survival after Orthotopic Liver Transplantation[J].J Hepatol Gastroint Dis,2015,1(106):2.
[13] 張志英,湯振源.重癥感染患者血降鈣素原和C反應(yīng)蛋白水平測(cè)定的臨床意義[J].中國(guó)血液流變學(xué)雜志,2012,22(4):607-609.
[14] 王艷,劉穎,葛艷玲,等.血清降鈣素原及C反應(yīng)蛋白檢測(cè)在早期診斷燒傷患者感染中的應(yīng)用價(jià)值[J].中華醫(yī)院感染學(xué)雜志,2013,23(14):3558-3560.
[15] Hegazy MA,Omar AS,Samir N,et al.Amalgamation of procalcitonin,C-reactive protein,and sequential organ failure scoring system in predicting sepsis survival[J].Anesthesia,essays and researches,2014,8(3):296.
(收稿日期:2017-04-13)